February 22, 2012 — HeartWare International Inc. announced that a U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel will review the premarket approval (PMA) application for the HeartWare Ventricular Assist Device system on April 25, 2012.

February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for achieving rhas received the CE mark. Paradise is designed to treat patients with resistant hypertension (HTN), a major risk factor for cardiovascular disease.

February 20, 2012 — U.S. Senate and House legislators have reached a “doc fix” agreement this week to prevent slashing payments to physicians treating Medicare patients. A law was to take effect at the beginning of March would have reduced reimbursements by 27 percent.

February 20, 2012 — BG Medicine, Inc. announced positive results from its pivotal validation study for the CardioSCORE diagnostic test, previously known by the development name AMIPredict.

February 20, 2012 — As part of president Obama’s pledge to reduce regulatory burden, Health and Human Services (HHS) secretary Kathleen Sebelius announced HHS will postpone the date at which certain health care entities have to comply with International Classification of Diseases, 10th Edition (ICD-10) diagnosis and procedure codes.

February 16, 2012 — Few hospitals have as much experience with the Berlin Heart pediatric ventricular assist device (VAD) as DMC Children's Hospital of Michigan. This is why the U.S. Food and Drug Administration (FDA) was eager to hear testimony from Henry L. Walters III, M.D., the hospital’s chief of cardiovascular surgery.